Literature DB >> 32819077

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge

Sudhir Kumar1, Ajay Gogia1, Ritu Gupta2, Soumya Mallick3.   

Abstract

Entities:  

Keywords:  CLL; Cutaneous involvement; Rash

Mesh：

Year:  2020        PMID： 32819077      PMCID： PMC7702654          DOI： 10.4274/tjh.galenos.2020.2020.0331

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN： 1300-7777            Impact factor:   1.831


× No keyword cloud information.
  6 in total

Review 1.  Hematological malignancy associated with polymyositis and dermatomyositis.

Authors:  I Marie; L Guillevin; J-F Menard; P Y Hatron; P Cherin; Z Amoura; P Cacoub; H Bachelez; A Buzyn; G Le Roux; J M Ziza; P Brice; J N Munck; F Sarrot-Reynauld; J C Piette; C Larroche
Journal:  Autoimmun Rev       Date:  2011-10-30       Impact factor: 9.754

2.  Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation.

Authors:  N E Kay
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

3.  Rituximab in the treatment of dermatomyositis: an open-label pilot study.

Authors:  Todd D Levine
Journal:  Arthritis Rheum       Date:  2005-02

Review 4.  Inflammatory myopathies and lymphoma.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol Sci       Date:  2016-08-31       Impact factor: 3.181

5.  Non-hemic autoimmunity in CLL.

Authors:  Terry J Hamblin
Journal:  Leuk Res       Date:  2008-10-18       Impact factor: 3.156

Review 6.  Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.

Authors:  Harsha Gunawardena; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.